Thank you for subscribing!
Finfeed Archived Mar 17, 2021
Bod Australia (ASX: BDA) is a cannabis centric healthcare company, with well-branded premium, proven and trusted products within two distinct verticals: Medical Cannabis and CBD and Hemp Consumer products.
Finfeed Archived Nov 26, 2020
The Therapeutic Goods Administration (TGA) will shortly bring down its final decision regarding a major regulatory change in the distribution of cannabidiol (CBD) products in Australia, which could hellp stocks such as Creso Pharma (ASX: CPH).
Finfeed Archived Oct 13, 2020
Creso Pharma Limited (ASX: CPH, FRA: 1X8) has once again strengthened its revenue profile with another repeat purchase order from South African-based Pharma Dynamics.
Next Investors Archived Oct 13, 2020
While Creso Pharma (ASX: CPH) continues to sign purchase orders and has appointed Bruce Linton as an advisor, it is a highly speculative investment, and our intent is to hold for the coming months through to Christmas to see how the company’s strategy plays out.
Get expert stock analysis direct in your inbox
Finfeed Archived Oct 07, 2020
World leading cannabis executive Bruce Linton has joined Creso Pharma (ASX: CPH) as a strategic advisor with a mandate to use his industry experience to progress the company’s global expansion.
Finfeed Archived Mar 24, 2020
The $9.9 million capped Australian-listed Creso Pharma Limited (ASX: CPH) is set to release CBD hemp teas in Q3 2020
Next Investors Archived Mar 24, 2020
Creso Pharma Limited (ASX: CPH) is expanding its available product line with the release of a hemp tea in Q3 2020.
Next Investors Archived Feb 11, 2020
Creso Pharma (ASX:CPH) today announced the successful development of anibidiol®EQUI, a flavoured micromilled hemp plant product for equines and large animals.
Finfeed Archived Feb 11, 2020
Creso Pharma (ASX:CPH) has successfully developed anibidiol®EQUI, a flavoured micromilled hemp plant product for equines and large animals.
Join Our Mailing List
